Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

PATENTS

Analysis of the standard for accepting supplementary experimental data in China’s patent practice

Nature Biotechnology volume 38, pages 27–29 (2020)Cite this article

Subjects

Balancing the interests of the applicants and the public, China has imposed strict restrictions on the examination of supplementary experimental data.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Patent Reexamination Board patent invalidation decision no. 34432 (China National Intellectual Property Administration, 2018).

  2. Liu, M. & Zheng C. Examination criteria for supplementing experimental data in the patent application for biomedical products. China Intellectual Property News (February 2017).

  3. Zhang, Q. Review and prospect on the focus during patent examination of chemical and pharmaceutical inventions—about the request and supplementary for experimental data. China Invention & Patent 8, 13–20 (2018).

  4. Dong, H. Examination criteria for supplementary experimental data after the date of application. China Intellectual Property News (May 2018).

  5. China Patent Law, Article 26.3 (2009).

  6. China Patent Law, Article 22.3 (2009).

  7. Supreme People’s Court. SPC XS No. 1878 Administrative Ruling (2016).

  8. Supreme People’s Court. ZXZ No. 41 Administrative Ruling (2012).

  9. Liu, M. Consideration and standard construction of supplementary experimental data in biomedical field—from the perspective of creativity. Sci. Technol. Law 5, 16–22 (2017).

    Article  Google Scholar 

  10. Supreme People’s Court. XTZ No. 8 Administrative Ruling (2016).

  11. Beijing Municipal High People’s Court (2017) JXZ No. 1642 Administrative Ruling (2017).

  12. Beijing Municipal High People’s Court (2017) JXZ No. 1806 Administrative Ruling (2017).

Download references

Author information

Authors and Affiliations

  1. Zhejiang University of Finance and Economics Law School, Hangzhou, China

    Wei Li

Authors
  1. Wei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Li.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, W. Analysis of the standard for accepting supplementary experimental data in China’s patent practice. Nat Biotechnol 38, 27–29 (2020). https://doi.org/10.1038/s41587-019-0365-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-019-0365-y

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing